Emergent BioSolutions (EBS) Signs $911M CDC Follow-On Contract for Anthrax Vaccine
Go back to Emergent BioSolutions (EBS) Signs $911M CDC Follow-On Contract for Anthrax Vaccine| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 4.66 +0.16 (3.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.50 | 52 Week High | $44.38 | |||
| Open | $4.46 | 52 Week Low | $24.47 | |||
| Day High | $4.67 | P/E | 233.00 | |||
| Day Low | $4.46 | EPS | $0.02 | |||
| Volume | 746,204 | |||||
